SCHEMBL9976724

SCHEMBL9976724

CCCCCCCCc1ccc(-n2c3ccc(-c4ccccc4)cc3c3cc4c(cc32)c2cc(-c3ccccc3)ccc2n4-c2ccc(CCCCCCCC)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.48
RARB P10826 8/20 0.44
RARA P10276 2/20 0.44
RARG P13631 1/20 0.44
EP300 Q09472 1/20 0.44
KAT2A Q92830 1/20 0.44
KAT2B Q92831 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
MTOR P42345 1/20 0.44
KMT2A Q03164 1/20 0.44
RORA P35398 1/20 0.44
RORC P51449 1/20 0.44
RORB Q92753 1/20 0.44
ICMT O60725 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15165494 0.87 RORA (0.44) HSD11B1RARBRARARARGRORA
SCHEMBL29328807 0.87 HSD11B1 (0.45) HSD11B1RARBRARARARGEP300
SCHEMBL25785321 0.86 TSPO (0.42) HSD11B1RARBRARARARGEP300
SCHEMBL15165491 0.86 RORA (0.43) HSD11B1RARBRARARARGMEN1
SCHEMBL14107128 0.85 RORA (0.48) HSD11B1ALDH1A1RORARORCRORB
SCHEMBL552038 0.85 RORA (0.48) HSD11B1ALDH1A1RORARORCRORB
SCHEMBL18858863 0.85 RORA (0.48) HSD11B1ALDH1A1RORARORCRORB
SCHEMBL25810727 0.85 EP300 (0.45) HSD11B1RARBEP300KAT2AKAT2B
SCHEMBL21311144 0.85 RORA (0.50) RARBRARARARGMEN1ALDH1A1
SCHEMBL18858856 0.85 RORA (0.44) HSD11B1RORARORCRORBFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140088313-A1 SUBSTITUTED INDOLOCARBAZOLES XEROX CORPORATION (US) 2014-03-27 US disclosed
US-20120157689-A1 SUBSTITUTED INDOLOCARBAZOLES XEROX CORPORATION (US) 2012-06-21 US disclosed
US-8110690-B2 Substituted indolocarbazoles XEROX CORPORATION (US) 2012-02-07 US disclosed
US-20090036689-A1 SUBSTITUTED INDOLOCARBAZOLES XEROX CORPORATION (US) 2009-02-05 US disclosed
US-7456424-B2 Thin film transistors including indolocarbozoles XEROX CORPORATION (US) 2008-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036689-A1 SUBSTITUTED INDOLOCARBAZOLES HTR3C, HTR3A, AANAT HSD11B1 896/4885RARB 2764/4885RARA 3125/4885
US-20120157689-A1 SUBSTITUTED INDOLOCARBAZOLES HTR3C, HTR3A, AANAT HSD11B1 896/4885RARB 2764/4885RARA 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.